Gathering Momentum and Envisioning the Future: CSGCT 2024 China Symposium on Gene and Cell Therapies Grandly Opens in Suzhou
As early summer bids farewell to spring, the timing is perfect. From June 14, spanning two days, this event is jointly hosted by the CSGCT Committee and Hangzhou Jingke, co-organized by BioProcess Insider, BiG Biopharma Innovation Community, VCBeat New Medicine, and Biologics Circle, undertaken by Suzhou Shengjie, and supported by YaoWeilai.2024 China Summit on Gene and Cell Therapy (CSGCT), grandly opened at the Shishan International Conference Center in Suzhou!
Centering on hot topics such as cell therapy, gene therapy, mRNA technology, and nucleic acid drug research, the conference featured one main forum and seven sub-forums. It brought together more than 200 academicians, authoritative experts and scholars, and representatives from leading enterprises from home and abroad as keynote speakers and panelists to discuss current industry hotspots and pain points, and to jointly chart the future of innovative development in the pharmaceutical industry. The event also included numerous corporate exhibitions, with participation from business development (BD) representatives of over 15 global pharmaceutical companies, more than 50 investment institutions, and representatives from over 10 local industrial parks.
Opening Ceremony of the Conference
At the Opening Ceremony of the Main Forum,Mao Wei, Secretary of the Party Working Committee of Suzhou New District and Secretary of the Huqiu District Committee，Dr. Wu Zhenhua, Founder, Chairman/CEO of Hangzhou Jiayin BiotechnologyDelivered welcome remarks, respectively.
Mao Wei
Secretary of the Party Working Committee of Suzhou New District, Secretary of the Huqiu District Committee
Wu Zhenhua
Founder, Chairman/CEO of Hangzhou Jiayin Biotech
Xin Xin, Senior Director of Bioprocess Development and Manufacturing at Jiayin BiologyPreside over the opening ceremony and main forum of this conference.
Xin Xin
Senior Director of Bioprocess Development and Manufacturing, Jiayin Bio
Keynote Address: Macro-Level Guidance
The main forum was themed “Propelling China’s Advanced Therapy Industry into Globalization,”Professor at Stanford (Conference Co-Chair) Mark Kay、Director, CBER at FDA Peter Marks、Academician of the Chinese Academy of Sciences Tan Weihong、BCG Partner/Dr. Liu Yuting、UCSD professor Kirk HammondKeynote addresses were delivered on various themes, providing a comprehensive, multi-dimensional analysis of the industry’s current status and future development opportunities from perspectives including policy and scientific research. During the roundtable discussion, numerous experts, scholars, and entrepreneur representatives engaged in dialogue centered on the forum’s theme, conveying to attendees the innovative momentum driving industry development.
Exploring the Molecular Basis for Variation in AAV Transduction:Guiding the Selection of Optimal AAV Capsids for Clinical Trials
Mark Kay
Professor at Stanford (Co-Chair of the Conference)
Regulatory Efforts to Advance Gene Therapy
Peter Marks
Director, CBER at FDA
Nucleic Acid Drugs
Tan Weihong
Academician of the Chinese Academy of Sciences
Current Status and Prospects of CGT Research, Development, and Industrialization in China
Liu Yuting
BCG Partner/Ph.D.
Tackling Heart Failure and Diabetes with Gene Transfer
Kirk Hammond
UCSD professor
Advancing China's Advanced Therapy Industry Toward Globalization
Roundtable Moderator:Xiao Liu, Vice President of Business and Marketing at Xingcheng Bio
Panelists:Wu Zhenhua | Zhou Jingmin | Zhou Guoying | Wang Liqun
Following the conclusion of the main forum in the morning, seven parallel sub-forums were held, focusing on topics such as “Frontiers in Cell Therapy,” “The Technological Revolution in Gene Therapy,” “Expanded Applications of mRNA Technology,” “Advances in Nucleic Acid Drug Research,” “CMC and Manufacturing,” “Clinical Progress in CGT,” and “Entrepreneurship, Investment, and Global Collaboration.” Over one hundred speakers delivered forward-looking insights and shared their successful case studies and practical experiences.
Roundtable Forum: Covering Industry Hot Topics
During the roundtable discussion, experts engaged in lively exchanges and interactions on several hot topics, including technological breakthroughs and future prospects for universal cell therapies, trends and experiential insights in rAAV vector engineering, and the application prospects of mRNA medicine. Their dynamic dialogue generated valuable insights, contributing intellectual wisdom to the industry’s development.
Day 1 of the conference concluded successfully. We look forward to equally compelling guest presentations at tomorrow’s (June 15) thematic forum!
Highlights
About
CSGCT
To facilitate the smooth and rapid development of China’s CGT industry, foster multi-party collaboration in technology and commercialization, and build a specialized industrial ecosystem for CGT, we have meticulously created the “2024 China Symposium on Gene and Cell Therapies (CSGCT 2024).” This initiative aims to establish a high-quality platform for industry exchange, promote international industrial integration, and support the construction and upgrading of China’s cell and gene therapy supply chain and ecosystem.